Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Patrick Scholes Bullish on Ready Capital with Buy Rating and Increased Price Target

Elaine Mendonca by Elaine Mendonca
March 1, 2024
in Breaking News
0
Finance_ Chart Down
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

Analyst Patrick Scholes from Truist Securities is bullish on Ready Capital (NYSE:RC), giving it a Buy rating and raising the price target to $151. Scholes, known for his success rate of 51% and average return of 5.10% per rating, specializes in lodging and leisure equity research. His recent recommendations also include Buy ratings for Marriott Vacations Worldwide, Hilton Grand Vacations, and Bluegreen Vacations Holding. Truist Securities, a division of Truist Financial Corporation, provides comprehensive capital markets and investment banking services to corporate and institutional clients.

RC Stock Shows Positive Momentum Despite Challenges: Investors Should Exercise Caution and Monitor Performance

On March 1, 2024, RC stock showed some positive price momentum as it experienced a 4.00% increase, rising $0.34 from its previous closing price of $8.83. Despite this increase, RC is still trading near the bottom of its 52-week range and below its 200-day simple moving average, indicating that the stock may still be facing some challenges in terms of overall performance. In pre-market trading, RC stock dropped slightly by $0.01, which could suggest some volatility in the stock’s price movement throughout the day. Investors should keep an eye on how the stock performs during regular trading hours to see if it can maintain its positive momentum or if it will face further fluctuations. It is important for investors to consider the broader market conditions and any company-specific news or events that could impact RC stock’s performance. By staying informed and conducting thorough research, investors can make more informed decisions about their investment strategies. Overall, while RC stock showed some positive price momentum on March 1, 2024, it is important for investors to exercise caution and closely monitor the stock’s performance to make informed decisions about their investments.

RC Stock Shows Promising Performance with 30.1% Revenue Increase in 2024

On March 1, 2024, RC stock showed promising performance based on the financial data provided by CNN Money. The company reported a total revenue of $1.14 billion for the past year, which represents a significant increase of 30.1% compared to the previous year. The net income of RC also showed positive growth, with a reported net income of $339.45 million for the past year, reflecting an impressive increase of 83.78% compared to the previous year. Earnings per share (EPS) for RC stock also demonstrated strong performance, with an EPS of $2.22 for the past year, showing an increase of 47.23% compared to the previous year. Overall, the financial performance of RC stock on March 1, 2024, indicates positive growth in total revenue, net income, and earnings per share compared to the previous year. Investors may view this data as a positive indicator of the company’s financial health and potential for future growth.

Tags: RC
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Market Capitalization

Analysts Bullish on MoonLake Immunotherapeutics Positive Outlook for MLTX

The Rise of Strategic Partnerships in Life Sciences: Trends Shaping the Future of Healthcare Innovation

Nvidias Transformation From Gaming Chips to AI Dominance

Wedbush Analyst Reaffirms Bullish Rating on ORIC Pharmaceuticals with Increased Price Target

Recommended

Super Micro Computer Stock

Super Micro Stock Surges Amid AI Infrastructure Boom

4 months ago
Adobe Stock

Adobe’s AI Ambitions Face Investor Skepticism

4 months ago
IBM Stock

Strong IBM Earnings Fail to Impress Market as Key Segment Shows Weakness

4 months ago
Inozyme Pharma Inc Stock

Inozyme Pharma Acquisition Finalized: Strategic Focus Shifts to Clinical Development

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

Trending

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

by Rodolfo Hanigan
February 7, 2026
0

Investor attention turns to Orthofix Medical as the company bolsters the clinical support for its biologics business...

CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes
  • Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com